ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 2 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $568,681 | -69.4% | 27,288 | -64.9% | 0.02% | -68.6% |
| Q2 2023 | $1,860,652 | -49.8% | 77,689 | -60.5% | 0.07% | -54.5% |
| Q1 2023 | $3,705,846 | +1631.7% | 196,910 | +1403.1% | 0.15% | +1825.0% |
| Q3 2022 | $214,000 | -89.2% | 13,100 | -90.7% | 0.01% | -90.7% |
| Q2 2022 | $1,984,000 | +23.7% | 140,769 | +112.5% | 0.09% | +24.6% |
| Q1 2022 | $1,604,000 | -16.8% | 66,244 | -16.2% | 0.07% | -62.9% |
| Q2 2021 | $1,928,000 | – | 79,060 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 82,723 | $2,685,000 | 20.75% |
| HWG Holdings LP | 289,380 | $9,393,000 | 8.72% |
| Baker Brothers Advisors | 24,516,738 | $795,813,000 | 8.34% |
| HARVEY CAPITAL MANAGEMENT INC | 352,200 | $11,432,000 | 5.73% |
| Belmont Global Advisors, Inc. | 150,000 | $4,869,000 | 4.67% |
| Palo Alto Investors LP | 1,437,730 | $46,669,000 | 3.52% |
| Avoro Capital Advisors LLC | 329,500 | $10,696,000 | 2.38% |
| GARRISON BRADFORD & ASSOCIATES INC | 70,100 | $2,275,000 | 2.23% |
| WEATHERBIE CAPITAL, LLC | 401,642 | $13,037,000 | 1.85% |
| ACUTA CAPITAL PARTNERS, LLC | 85,999 | $2,792,000 | 1.34% |